posted on 2025-03-28, 06:04authored byTatiane
Patrícia Babinski, Ariane Krause Padilha Lorenzett, Jeferson Ziebarth, Vanderlei Aparecido de Lima, Rubiana Mara Mainardes
Zein-based nanoparticles
offer significant potential as carriers
for drug delivery due to their biocompatibility. However, optimizing
their formulation is essential to achieving efficient encapsulation
and stability. This study aimed to optimize the formulation of zein-casein-hyaluronic
acid-based nanoparticles for the encapsulation of a hydrophilic drug,
focusing on achieving favorable physicochemical properties for oral
drug delivery applications. A factorial experimental design was employed
to evaluate the influence of key formulation parameters, including
zein concentration, hyaluronic acid concentration, sodium caseinate
concentration, and the organic-to-aqueous phase (O/W) ratio. Particle
size (PS), polydispersity index (PDI), zeta potential, and encapsulation
efficiency (EE) were analyzed as response variables. Multivariate
analyses, such as hierarchical cluster analysis and principal component
analysis, were performed to explore the relationships between formulation
parameters and nanoparticle properties. Model validity was confirmed
by using ANOVA and residual analysis. Optimized nanoparticles exhibited
a PS of 217 ± 5 nm, PDI of 0.077 ± 0.022, zeta potential
of −24.7 ± 1.9 mV, and EE of 31% ± 4. The nanoparticles
displayed a monomodal size distribution and a spherical morphology.
Multivariate analyses revealed that the O/W ratio and zein concentration
were the most influential factors, while sodium caseinate played a
crucial stabilizing role. The desirability function yielded a high
score (D = 0.9338), confirming the robustness of
the optimization process. Stability studies demonstrated that refrigeration
at 8 °C preserved the nanoparticles’ physicochemical properties
over 180 days. This study underscores the power of experimental design
as a tool to refine nanoparticle formulations, paving the way for
more efficient drug delivery systems and unlocking new possibilities
for the oral administration of hydrophilic compounds.